![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Mary_Broadfoot_Walker_1920s.jpg/640px-Mary_Broadfoot_Walker_1920s.jpg&w=640&q=50)
Mary Broadfoot Walker
British physician / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Mary Broadfoot Walker?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Mary Broadfoot Walker (17 April 1888 – 13 September 1974) was a Scottish physician who first demonstrated the effectiveness of physostigmine in the treatment of the condition myasthenia gravis, a disease relating to muscle weakness. She was also the first to recognise the association between familial periodic paralysis and low blood potassium levels.
Quick Facts Dr. Mary Broadfoot Walker, Born ...
Dr. Mary Broadfoot Walker | |
---|---|
![]() Dr Mary Walker in the 1920s | |
Born | (1888-04-17)17 April 1888 |
Died | 13 September 1974(1974-09-13) (aged 86) |
Education | University of Edinburgh Edinburgh College of Medicine for Women |
Years active | 1913–1974 |
Known for | Treatment of myasthenia gravis with physostigmine Association of familial periodic paralysis and hypokalaemia |
Medical career | |
Profession | physician |
Institutions | St Alfege's Hospital, Greenwich St Leonard's Hospital, Shoreditch St Francis' Hospital, Dulwich St Benedict's Hospital, Tooting Glasgow Royal Maternity and Women's Hospital |
Research | Myasthenia gravis Familial periodic paralysis |
Awards | Royal College of Physicians Jean Hunter Prize (1962) |
Close